[1] [1] Blaser MC, Kraler S, Lscher TF, et al. Multi-omicsapproaches to define calcific aortic valve disease pathogenesis[J]. Circ Res, 2021, 128(9): 1371-1397.

[2] [2] Vankayalapati DK, Segun-Omosehin O, El Ghazal N, et al. Long-term outcomes of mechanical versus bioprosthetic aortic valve replacement: a systematic review and meta-analysis[J]. Cureus, 2024, 16(1): e52550.

[3] [3] Unai S, Ozaki S, Johnston DR, et al. Aortic valve reconstruction with autologous pericardium versus a bioprosthesis: the Ozaki procedure in perspective[J]. J Am Heart Assoc, 2023, 12(2): e027391.

[4] [4] von Stumm M, Sequeira-Gross T, Petersen J, et al. Narrative review of the contemporary surgical treatment of unicuspid aortic valve disease[J]. Cardiovasc Diagn Ther, 2021, 11(2): 503-517.

[5] [5] Steitz M, Zouhair S, Khan MB, et al. A glutaraldehyde-free crosslinking method for the treatment of collagen-based biomaterials for clinical application[J]. Bioengineering (Basel), 2023, 10(11): 1247.

[6] [6] K Awad A, Farahat RA, Reda Gad E, et al. Does Ozaki procedure have a future as a new surgical approach for aortic valve replacement? a systematic review and meta-analysis[J]. Ann Med Surg (Lond), 2023, 85(9): 4454-4462.

[7] [7] Sivalingam S, Haranal M, Pathan IH. Aortic valve neocuspidization for aortic regurgitation associated with ventricular septal defect[J]. Interact Cardiovasc Thorac Surg, 2022, 34(2): 315-321.

[8] [8] Ramirez AD, Losito C, Di Bari N, et al. Tricuspid aortic valve reconstruction with autologous pericardium (ozaki technique) in bicuspid aortic valve infective endocarditis[J]. Braz J Cardiovasc Surg, 2023, 38(2): 309-311.

[9] [9] Badalyan SS, Markosyan SV, Ismailbaev AM, et al. Outcomes of Ozaki procedure/aortic valve neocuspidization for aortic valve diseases: a systematic review[J]. Anatol J Cardiol, 2023, 27(11): 619-627.

[10] [10] Patel V, Unai S, Moore R, et al. The Ozaki procedure: standardized protocol adoption of a complex innovative procedure[J]. Struct Heart, 2024, 8(1): 100217.

[11] [11] Feng Y, Zhang B, Li J, et al. Morphology optimization of leaf let for surgical reconstruction of the aortic valve: in vitro test and simulation-based DOE study[J]. J Cardiovasc Transl Res, 2023, 16(1): 177-191.

[12] [12] Dittfeld C, Bhring S, Welzel C, et al. Tissue requirements for the application of aortic valve neocuspidization-appropriate pericardium properties and homogeneity?[J]. J Mater Sci Mater Med, 2024, 35(1): 26.

[13] [13] Hofferberth SC, Baird CW, Hoganson DM, et al. Mechanical properties of autologous pericardium change with fixation time: implications for valve reconstruction[J]. Semin Thorac Cardiovasc Surg, 2019, 31(4): 852-854.

[14] [14] Gardin C, Morciano G, Ferroni L, et al. Biological characterization of human autologous pericardium treated with the Ozaki procedure for aortic valve reconstruction[J]. J Clin Med, 2021, 10(17): 3954.

[15] [15] Williams DF, Bezuidenhout D, de Villiers J, et al. Long-term stability and biocompatibility of pericardial bioprosthetic heart valves[J]. Front Cardiovasc Med, 2021, 8: 728577.

[16] [16] Bazylev V, Tungusov D, Mikulyak A. Predictors of mid-term AVNeo insufficiency[J]. Braz J Cardiovasc Surg, 2023, 38(6): e20220370.

[17] [17] Marathe SP, Chvez M, Sleeper LA, et al. Modified Ozaki procedure including annular enlargement for small aortic annuli in young patients[J]. Ann Thorac Surg, 2020, 110(4): 1364-1371.

[18] [18] Cicek M, Ozdemir F. Aortic valve neocuspidization with the Ozaki procedure in congenital aortic valve disease: early results[J]. Turk Gogus Kalp Damar Cerrahisi Derg, 2023, 31(4): 431-439.

[19] [19] Fazzari F, Baggiano A, Fusini L, et al. Early biological valve failure: structural valve degeneration, thrombosis, or endocarditis?[J]. J Clin Med, 2023, 12(17): 5740.

[20] [20] Mylonas KS, Tasoudis PT, Pavlopoulos D, et al. Aortic valve neocuspidization using the Ozaki technique: a meta-analysis of reconstructed patient-level data[J]. Am Heart J, 2023, 255: 1-11.

[21] [21] Fukunaga N, Tamura N. Mitral valve repair with glutaraldehyde-treated autologous pericardium for active infective endocarditis[J]. Gen Thorac Cardiovasc Surg, 2022, 70(7): 683-684.

[22] [22] Benedetto U, Gergely S, Dimagli A, et al. AVNeo (Ozaki) and transaortic mitral valve repair using autologous pericardium only for aortomitral endocarditis[J]. JTCVS Tech, 2020, 3: 101-103.

[23] [23] Secinaro A, Milano EG, Ciancarella P, et al. Blood flow characteristics after aortic valve neocuspidization in paediatric patients: a comparison with the Ross procedure[J]. Eur Heart J Cardiovasc Imaging, 2022, 23(2): 275-282.

[24] [24] Saisho H, Scharfschwerdt M, Schaller T, et al. Ex vivo evaluation of the Ozaki procedure in comparison with the native aortic valve and prosthetic valves[J]. Interact Cardiovasc Thorac Surg, 2022, 35(3): ivac199.

[25] [25] Prinzing A, Boehm J, Burri M, et al. Midterm results after aortic valve neocuspidization[J]. JTCVS Tech, 2024, 25: 35-42.

[26] [26] Lansakara M, Unai S, Ozaki S. Ozaki procedure-re-construction of aortic valve leaflets using autologous pericardial tissue: a review[J]. Indian J Thorac Cardiovasc Surg, 2023, 39(Suppl 2): 260-269.

[27] [27] Khatchatourov G, van Steenberghe M, Goy D, et al. Short-term outcomes of aortic valve neocuspidization for various aortic valve diseases[J]. JTCVS Open, 2021, 8: 193-202.

[28] [28] Russo MJ, Thourani VH, Cohen DJ, et al. Minimally invasive versus full sternotomy for isolated aortic valve replacement in low-risk patients[J]. Ann Thorac Surg, 2022, 114(6): 2124-2130.